The critical role of MPO in several cardiovascular diseases, such as atherosclerosis, myocardial infarction, arrhythmia, and pulmonary hypertension [24, 46] led to clinical development of oral MPO inhibitors [40]. This evidence concerns the gene MPO and pulmonary arterial hypertension.